비티젠(BTGEN)
Incheon, South Korea btgen.co.kr From their website, Nov 2026
- GMP
Work here? Claim this listing
About
BTGEN is a company that provides contract development and manufacturing (CDMO/CMO) for biopharmaceuticals, from cell culture to purification, filling and packaging, and quality testing. It is located in Songdo-dong, Yeonsu-gu, Incheon Metropolitan City, and provides clinical and commercial production of biopharmaceuticals to client companies.
Services
Process Development
Performs cell line development, USP development, DSP development, formulation development, and analytical method development.
Technology Transfer
Transfers processes from client companies, and supports scale-up process design and analytical method transfer and validation.
Engineering Runs
Performs scale-up engineering runs for DS/DP processes.
Release Testing
Performs DS/DP release testing.
Preliminary Stability Testing
Performs initial stability testing of DS/DP.
cGMP DS Manufacturing
Performs DS manufacturing and purification based on mammalian cell culture.
cGMP DP Manufacturing
바이알 또는 pre-filled syringe 형태의 DP 충전 및 2차 포장을 수행합니다.
Analytical Testing
Performs physicochemical, microbiological, and cell-based testing, and raw materials, DS/DP, stability, and similarity/comparability testing.
4 more services
- Regulatory Services
- Quality Assurance
- Project Management System
- Scale-up Engineering
Capabilities
- Assays and studies
- Process development
- Analytical development
- Physicochemical testing
- Microbial testing
- Cell-based bioassay
- Stability testing
16 more
- Chromatographic testing
- Identification of active ingredients and impurities
- Limit tests
- Water analysis
- Microbial limit testing
- Sterility testing
- Bacterial endotoxin testing
- Bioburden testing
- EM (environmental monitoring)
- Cytotoxicity (ADCC and CDC)
- Cell-based testing
- Raw materials testing
- DS/DP release testing
- Similarity testing
- Comparability testing
- HPLC
- Scale and capacity
- 500L single-use bioreactor
- 2,000L buffer preparation capacity
- 3 lines of 2,500L bioreactors
- 2,500L cell culture capacity
- 3,000L harvest vessel
- Up to 9,000L planned facility expansion
5 more
- More than 100-200 batches per year
- cGMP DS manufacturing
- cGMP DP manufacturing
- Mammalian cell culture max. 2,500L
- Plan to expand facility to 9,000L (2023 Q3)
Instruments and platforms
- HPLC
- CE
- ICP-OES
- UV/Vis spectrophotometer
- Ion Chromatography
- GC
9 more
- TOC analyzer
- pH/conductivity meter
- RT-PCR System
- Microplate Reader
- Luminescence Microplate Reader
- Incubator
- Biosafety Cabinet
- Endotoxin Detection System (MCS)
- AKTA Process & Column
Modalities and species
- Modalities
- Recombinant protein
- Biosimilar
- Species and models
- Mammalian cell culture
- Single-use system
- Multi-use system
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Scope: quality management system, DS manufacturing, DP manufacturing
Industries served
- Biopharmaceuticals
Details
- Type
- CRDMO
- Based in
- Incheon, South Korea
- Serves
- Korea, Japan, Europe, Turkey, KR, JP, EU, US
- cs@btgen.co.kr on their site
- Phone
- 00-000-0000